TACE With Thermosensitive Nanogel Versus Embosphere for HCC
NCT06593964
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
188
Enrollment
OTHER
Sponsor class
Conditions
Unresectable Hepatocellular Carcinoma
Interventions
DEVICE:
Thermosensitive Nanogel Embolic Agent
Sponsor
Zhongda Hospital